243 related articles for article (PubMed ID: 16494110)
1. Biological therapies in autoimmune chronic inflammatory diseases (ACIDs).
Ferraccioli GF; Gremese E
Eur Rev Med Pharmacol Sci; 2006; 10(1):37-40. PubMed ID: 16494110
[TBL] [Abstract][Full Text] [Related]
2. Beyond tumor necrosis factor: next-generation biologic therapy for inflammatory bowel disease.
Podolsky DK
Dig Dis; 2009; 27(3):366-9. PubMed ID: 19786766
[TBL] [Abstract][Full Text] [Related]
3. Keys to unlocking the mysteries of rheumatic autoimmune disease.
Moser KL; Gaffney P; Peterson E; Behrens T
Minn Med; 2004 May; 87(5):46-51. PubMed ID: 15191068
[TBL] [Abstract][Full Text] [Related]
4. Safety issues with biological therapies for inflammatory bowel disease.
Van Assche G; Vermeire S; Rutgeerts P
Curr Opin Gastroenterol; 2006 Jul; 22(4):370-6. PubMed ID: 16760752
[TBL] [Abstract][Full Text] [Related]
5. [Treatment with tacrolimus in autoimmune diseases].
Sádaba B; Azanza JR; García Quetglas E; Fernández V
Rev Med Univ Navarra; 2004; 48(3):24-38. PubMed ID: 15622922
[TBL] [Abstract][Full Text] [Related]
6. mAbs in nonlupus autoimmune rheumatic disease.
Whelan BR; Isenberg DA
Curr Opin Hematol; 2009 Jul; 16(4):280-4. PubMed ID: 19444098
[TBL] [Abstract][Full Text] [Related]
7. New mediators of immunity and inflammation in inflammatory bowel disease.
Monteleone G; Fina D; Caruso R; Pallone F
Curr Opin Gastroenterol; 2006 Jul; 22(4):361-4. PubMed ID: 16760750
[TBL] [Abstract][Full Text] [Related]
8. Chronic health effects of microbial foodborne disease.
Bunning VK; Lindsay JA; Archer DL
World Health Stat Q; 1997; 50(1-2):51-6. PubMed ID: 9282386
[TBL] [Abstract][Full Text] [Related]
9. Interplay of commensal and pathogenic bacteria, genetic mutations, and immunoregulatory defects in the pathogenesis of inflammatory bowel diseases.
Packey CD; Sartor RB
J Intern Med; 2008 Jun; 263(6):597-606. PubMed ID: 18479259
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune disorders in patients affected by celiac sprue and inflammatory bowel disease.
Bardella MT; Elli L; De Matteis S; Floriani I; Torri V; Piodi L
Ann Med; 2009; 41(2):139-43. PubMed ID: 18777226
[TBL] [Abstract][Full Text] [Related]
11. Cortistatin as a potential multistep therapeutic agent for inflammatory disorders.
Gonzalez-Rey E; Delgado M
Drug News Perspect; 2006 Sep; 19(7):393-9. PubMed ID: 17080202
[TBL] [Abstract][Full Text] [Related]
12. Immunologic and genetic links between spondylarthropathies and inflammatory bowel diseases.
Faustini F; Zoli A; Ferraccioli GF
Eur Rev Med Pharmacol Sci; 2009 Mar; 13 Suppl 1():1-9. PubMed ID: 19530505
[TBL] [Abstract][Full Text] [Related]
13. [Aminosalicylates and steroids in the treatment ot chronic inflammatory bowel diseases--consensus paper of the Working Group for Chronic Inflammatory Bowel Diseases of the OGGH].
Dejaco C; Haas T; Kirchgatterer A; Miehsler W; Wenzl H; Knoflach P; Petritsch W; Vogelsang H; Reinisch W; Tilg H
Z Gastroenterol; 2006 Jun; 44(6):525-38; discussion 539. PubMed ID: 16773519
[TBL] [Abstract][Full Text] [Related]
14. Boswellic acids in chronic inflammatory diseases.
Ammon HP
Planta Med; 2006 Oct; 72(12):1100-16. PubMed ID: 17024588
[TBL] [Abstract][Full Text] [Related]
15. How to outfox mother nature--autoimmunity: moving from shadows to sunshine.
Borchers AT; Keen CL; Shoenfeld Y; Gershwin ME
Isr Med Assoc J; 2000 Jul; 2 Suppl():15-22. PubMed ID: 10909412
[TBL] [Abstract][Full Text] [Related]
16. Current medical therapy for chronic inflammatory bowel diseases.
Tamboli CP
Surg Clin North Am; 2007 Jun; 87(3):697-725. PubMed ID: 17560421
[TBL] [Abstract][Full Text] [Related]
17. Homeostatic (IL-7) and effector (IL-17) cytokines as distinct but complementary target for an optimal therapeutic strategy in inflammatory bowel disease.
Kanai T; Nemoto Y; Kamada N; Totsuka T; Hisamatsu T; Watanabe M; Hibi T
Curr Opin Gastroenterol; 2009 Jul; 25(4):306-13. PubMed ID: 19448533
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic targeting of alpha 4-integrins in chronic inflammatory diseases: tipping the scales of risk towards benefit?
Engelhardt B; Briskin MJ
Eur J Immunol; 2005 Aug; 35(8):2268-73. PubMed ID: 16052610
[TBL] [Abstract][Full Text] [Related]
19. [Advances in biologic therapy for inflammatory bowel disease].
Sostegni R; Pera A; Daperno M; Rocca R
Recenti Prog Med; 2008 Jan; 99(1):10-8. PubMed ID: 18389866
[TBL] [Abstract][Full Text] [Related]
20. The plant sterol guggulsterone attenuates inflammation and immune dysfunction in murine models of inflammatory bowel disease.
Mencarelli A; Renga B; Palladino G; Distrutti E; Fiorucci S
Biochem Pharmacol; 2009 Nov; 78(9):1214-23. PubMed ID: 19555671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
